SANUWAVE Health, Inc.  

(Public, OTCBB:SNWV)   Watch this stock  
Find more results for SNWV)
0.170
+0.010 (6.19%)
Mar 5 - Close
OTCBB data delayed by 15 mins - Disclaimer
Currency in USD
Range 0.16 - 0.17
52 week 0.04 - 0.81
Open 0.17
Vol / Avg. 102,511.00/169,199.00
Mkt cap 10.71M
P/E     -
Div/yield     -
EPS -0.16
Shares 50.71M
Beta 0.39
Inst. own 31%
May 11, 2015
Q1 2015 SANUWAVE Health Inc Earnings Release (Estimated) Add to calendar
Mar 4, 2015
Q4 2014 SANUWAVE Health Inc Earnings Call
Mar 3, 2015
Q4 2014 SANUWAVE Health Inc Earnings Release
  

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin -656.25% -1494.29%
Operating margin -619.60% -1177.88%
EBITD margin - -706.18%
Return on average assets -90.13% -695.33%
Return on average equity -1912.99% -
Employees 11 -
CDP Score - -

Address

Suite 150, 11475 Great Oaks Way
ALPHARETTA, GA 30022
United States - Map
+1-678-5816843 (Phone)
+1-770-4198634 (Fax)

Website links

Description

SANUWAVE Health, Inc. is a regenerative medicine company focused on the development and commercialization of noninvasive, biological response activating devices for the repair and regeneration of tissue, musculoskeletal and vascular structures. The Company focuses on developing its Pulsed Acoustic Cellular Expression technology to activate healing in wound conditions, including diabetic foot ulcers, venous ulcers, pressure sores, burns and other skin eruption conditions; orthopedic/spine applications, such as eliminating chronic pain in joints from trauma or arthritis, speeding the healing of fractures, improving bone density in osteoporosis, fusing bones in the extremities and spine, and other potential sports injury applications; plastic/cosmetic applications such as cellulite smoothing, graft and transplant acceptance, skin tightening, scarring and other potential aesthetic uses; and cardiac applications to remove plaque due to atherosclerosis and improving heart muscle performance.

Officers and directors

Kevin A. Richardson II Chairman of the Board, Co-Chief Executive Officer
Age: 46
Barry J. Jenkins Chief Financial Officer, Chief Operating Officer
Age: 50
John F. Nemelka Director
Age: 48
Alan L. Rubino Director
Age: 59